Natural Matrix Validation Using Spectroscopy and Cellular Assays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for validating therapeutic products derived from natural matrices, such as plant matrices, are inadequate as they rely solely on the reproducibility of chemical composition, failing to account for the complex interactions and emerging properties that arise from the supramolecular organization of these matrices, which are essential for their therapeutic effects.
Innovation Solution
A new method for validating batches of products comprising natural matrices using spectroscopy or spectrophotometry analysis, where acceptability ranges or cut-offs are defined based on biological activities in cellular assays, rather than mere chemical composition, ensuring compliance with regulatory standards for medical devices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If validation methods rely solely on chemical composition reproducibility, then manufacturing precision is improved, but the ability to capture emerging properties and supramolecular interactions is lost
Solution Approach 1:
The validation approach is segmented into multiple independent assessment dimensions: chemical composition analysis (traditional), spectroscopy-based supramolecular structure analysis, and cellular assay functional evaluation. Each dimension provides independent insights, and together they comprehensively validate both manufacturing precision and therapeutic reliability.
Solution Approach 2:
The validation methodology transitions from a single-dimensional chemical composition focus to a multi-dimensional assessment framework incorporating spectroscopic data (molecular arrangement dimension) and cellular functional responses (biological activity dimension). This dimensional expansion enables simultaneous evaluation of manufacturing precision and therapeutic effect consistency.
2Measurement precision
If spectroscopy analysis is used to assess supramolecular organization, then measurement precision of emerging properties is improved, but device complexity increases
Solution Approach 1:
Spectroscopy techniques are applied universally across multiple validation objectives: characterizing supramolecular organization, identifying emerging properties, and correlating with cellular functions. This multi-functional use of spectroscopy justifies the added complexity by providing comprehensive validation capabilities through a single analytical approach family.
Solution Approach 2:
Spectroscopic measurements serve as an intermediary bridge between the supramolecular structure (which cannot be directly observed) and the observed cellular effects. The spectroscopic data acts as a measurable proxy that correlates with both manufacturing quality and therapeutic activity, enabling indirect but comprehensive validation.
3Manufacturing precision
If validation focuses on individual chemical components, then manufacturing precision is improved, but the holistic therapeutic effect cannot be captured
Solution Approach 1:
The validation methodology merges traditional component-level chemical analysis with system-level spectroscopic and cellular assessments. This combination allows simultaneous quantification of individual components (maintaining manufacturing precision) and evaluation of holistic supramolecular organization and cellular effects (capturing therapeutic versatility).
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach ensures the reproducibility and quality control of natural matrix-based products by assessing their therapeutic effects on a holistic level, aligning with regulatory requirements and maintaining consistent biological activity across batches.
Implementation Method 1
a step in which said acceptability ranges or cut-offs are calculated on the spectroscopy or spectrophotometry spectra of a gold standard of said product
Data Source
AI summary
The present invention relates to a new method for assessing acceptability ranges or cut-offs for the compliance validation of batches of products comprising or consisting of one or more natural matrix, wherein said products have an ascertained therapeutic or beneficial effect. The invention also relates to a new process for the compliance validation of one or more batches of said products.